Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhBNP versus nitroglycerin for renal function in acute myocardial infarction with acute heart failure
ChiCTR-IPR-15005796Phase 4Recruiting
- Sponsor
- The Second Hospital of Hebei Medical University
- Start
- Jan 2015
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of nesiritide in myocardial infarction (MI) and Acute Heart Failure (AHF) (2 arms), sponsored by The Second Hospital of Hebei Medical University. Primary endpoints: Renal function, Heart function and 1 more. Started Jan 2015; status: recruiting.
02
Drugs
nesiritide
03
Conditions
myocardial infarction (MI)Acute Heart Failure (AHF)
Beyond the preview
Go deeper on ChiCTR-IPR-15005796.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-15005796.